NCT05612464

Brief Summary

Dystonia is a severely disabling movement disorder with no cure, in which people suffer painful muscle spasms causing twisting movements and abnormal postures. There are many causes, including genetic conditions and brain injury. The most common cause in childhood is dystonic cerebral palsy (CP) which often affects the whole body. The underlying mechanisms are unknown, but there is growing evidence to implicate abnormal brain processing by the brain of incoming "sensory" information (e.g., signals to the brain from our senses of touch and body position): the distorted perception of these signals disrupts the way the brain produces instructions for planning and performing movements. The investigator's previous studies have shown that the way the brain processes sensory information related to movement is abnormal in children with dystonia and dystonic CP, by using methods that record the EEG (electroencephalogram - brain wave signals) and/or EMG (electromyogram - electrical signal from muscles). A specific brain rhythm (called mu) typically shows well-defined changes in response to movement, and reflects processing of sensory information. The investigator's work shows these rhythm changes are abnormal in children with dystonia/dystonic CP. This study will explore if these findings can improve treatment. In particular the study team will investigate whether children and young people with dystonia/dystonic CP can enhance these mu rhythm responses during a movement task by using feedback of their brain rhythms displayed as a cartoon/game on a computer. The investigators will also assess whether enhanced mu activity is associated with improved movement control. This would open future possibilities to use such devices for therapy/rehabilitation. Children and young people with dystonia/dystonic CP aged 5-25 years will be recruited, along with age-matched controls. Studies will last 2-3 hours with time for breaks and will be conducted at Evelina London Children's Hospital and Barts Health Trust, with the option for home visits if preferable for families.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
21mo left

Started Feb 2023

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Feb 2023Feb 2028

First Submitted

Initial submission to the registry

October 24, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 10, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

November 10, 2022

Status Verified

October 1, 2022

Enrollment Period

5 years

First QC Date

October 24, 2022

Last Update Submit

November 9, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in mu modulation between trials with and without biofeedback

    During the procedure

Study Arms (3)

Primary dystonia group (genetic or idiopathic)

Other: No intervention

Dystonic cerebral palsy group

Other: No intervention

Control group

Other: No intervention

Interventions

No intervention

Control groupDystonic cerebral palsy groupPrimary dystonia group (genetic or idiopathic)

Eligibility Criteria

Age5 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Population to be researched is children/young people with dystonia / dystonic cerebral palsy. Age range 5-25 years

You may qualify if:

  • Control Group:
  • Age 5 -25 years
  • No known disorder of movement
  • Able to understand and participate in study.
  • Primary dystonia group (isolated genetic or idiopathic):
  • Age 5-25 years
  • Clinical dystonia - as confirmed on clinical assessment by consultant paediatric neurologist.
  • Genetic or idiopathic aetiology.
  • No other neurological abnormality.
  • Normal cranial magnetic resonance imaging (MRI).
  • Able to understand and participate in study.
  • Dystonic Cerebral Palsy Group:
  • Age 5-25 years
  • Clinical dystonia/dyskinesia - as confirmed on clinical assessment by consultant paediatric neurologist.
  • Documented history of perinatal hypoxic-ischaemic encephalopathy (HIE), prematurity \<35 weeks or kernicterus.
  • +3 more criteria

You may not qualify if:

  • Control Group:
  • Age \<5 or \>25 years
  • Any known disorder of movement.
  • Primary dystonia group (isolated genetic or idiopathic):
  • Age \< 5 or \>25 years
  • Presence of other neurological abnormality in addition to dystonia.
  • Abnormal cranial MRI.
  • Dystonic Cerebral Palsy Group:
  • Age \< 5 or \>25 years
  • No clear history of perinatal HIE, prematurity or kernicterus.
  • Predominant spasticity.
  • MRI scan not compatible with perinatal HIE, prematurity or kernicterus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

DystoniaDystonic Disorders

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsMovement DisordersCentral Nervous System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2022

First Posted

November 10, 2022

Study Start

February 1, 2023

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

February 1, 2028

Last Updated

November 10, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

The research team will have exclusive use of the data for the project duration and five years afterwards to allow for publications to be achieved. After this period, the majority of data would be made available for data sharing via the King's College London data repository. Only non-identifiable data will be available.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available approximately 5 years after the end of the study
Access Criteria
The data would be deposited within the institutional data repository at King's College London (KCL). Each dataset will have a data sharing policy, in line with MRC (Medical Research Council) guidance and KCL policies. Governance of access will be in line with these study-specific policies. The PI will be involved in making the decision-making process for access requests, along with the repository team.